David M. Tenero

The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency

T. W. B. Gehr, David M. Tenero, D. A. Boyle et al. · European Journal of Clinical Pharmacology · 1999 · 113 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers*

David J. Kazierad, David E. Martin, Robert A. Blum et al. · Clinical Pharmacology & Therapeutics · 1997 · 87 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Steady‐State Pharmacokinetics of Carvedilol and Its Enantiomers in Patients with Congestive Heart Failure

David M. Tenero, Steven C. Boike, Duane Boyle et al. · The Journal of Clinical Pharmacology · 2000 · 78 citations

Medicine, Pharmacokinetics, Pharmacology +13

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment

David M. Tenero, Geo Derimanov, Alex Carlton et al. · Antimicrobial Agents and Chemotherapy · 2019 · 73 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction

Milton Packer, Mary Ann Lukas, David M. Tenero et al. · The American Journal of Cardiology · 2006 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +16